gip glp 1 agonist Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research GLP-1 Drug Savings: A Complete
Description
Epub 2024 May 22
This two-pronged attack eat less, burn more is the Holy Grail of obesity medicine
Competing interests: All authors have completed the ICMJE uniform disclosure form at and declare: this study was funded by the Canadian Institutes of Health Research
They comment
Aslani A., Smith R
On Wegovy, patients lost an average of 17.4% of their body weight over the 68 week trial
